GRK2 and Alzheimer disease: Our study was the first where ultrastructural localization demonstrated that the overexpression of GRK2 occurs during the early stages of damage in aged human and AD cases (see Figures 1 and 2), and also in our 2-VO model of CBH (see Figures 3, 4, and 5).